1. Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis. (1st November 1999) Authors: Maini, R N; Taylor, P C; Paleolog, E; Charles, P; Ballara, S; Brennan, F M; Feldmann, M Journal: Annals of the rheumatic diseases Issue: Volume 58(1999)Supplement 1 Page Start: I56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗